PROTON PUMP INHIBITORS INHIBIT THE CARDIOVASCULAR ENZYME DDAH AND REGULATE PROCESSES UNDERLYING IDIOPATHIC PULMONARY FIBROSIS

被引：0
|
作者：
Ghebremariam, Y.
Zhou, Q.
de Andrade, J.
Ho, L.
Rosen, G.
Cooke, J.
机构：
来源：
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY | 2014年 / 115卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
135
引用
收藏
页码：42 / 42
页数：1
相关论文
共 23 条
  • [1] Proton pump inhibitors inhibit the cardiovascular enzyme DDAH and regulate processes underlying idiopathic pulmonary fibrosis
    Ghebremariam, Yohannes T.
    Zhou, Qingtao
    de Andrade, Joao
    Ho, Lawrence
    Rosen, Glenn D.
    Cooke, John P.
    VASCULAR MEDICINE, 2014, 19 (03) : 223 - 223
  • [2] Proton Pump Inhibitors Inhibit DDAH and Processes Underlying Idiopathic Pulmonary Fibrosis
    Ghebrernariam, Yohannes T.
    Ho, Lawrence
    Rosen, Glenn D.
    Cooke, John P.
    CIRCULATION, 2013, 128 (22)
  • [3] Proton Pump Inhibitors Inhibit Ddah And Improve Survival In Idiopathic Pulmonary Fibrosis
    Ho, L.
    Ghebremariam, Y.
    Cooke, J.
    Rosen, G.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [4] Idiopathic Pulmonary Fibrosis: Novel Concepts of Proton Pump Inhibitors as Antifibrotic Drugs
    Ghebre, Yohannes T.
    Raghu, Ganesh
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2016, 193 (12) : 1345 - 1352
  • [5] Effectiveness of proton pump inhibitors in idiopathic pulmonary fibrosis: A population-based cohort study
    Tran, Tanja
    Assayag, Deborah
    Ernst, Pierre
    Suissa, Samy
    PHARMACOEPIDEMIOLOGY AND DRUG SAFETY, 2020, 29 : 104 - 105
  • [6] Pathophysiological Studies Are Mandatory to Understand the Benefit of Proton Pump Inhibitors in Patients with Idiopathic Pulmonary Fibrosis
    Savarino, Edoardo
    Zentilin, Patrizia
    Marabotto, Elisa
    Savarino, Vincenzo
    JOURNAL OF NEUROGASTROENTEROLOGY AND MOTILITY, 2016, 22 (04) : 710 - 711
  • [7] Effectiveness of Proton Pump Inhibitors in Idiopathic Pulmonary Fibrosis A Population-Based Cohort Study
    Tran, Tanja
    Assayag, Deborah
    Ernst, Pierre
    Suissa, Samy
    CHEST, 2021, 159 (02) : 673 - 682
  • [8] The Role of Proton Pump Inhibitors in the Realm of Idiopathic Pulmonary Fibrosis and its Associated Comorbidities: A Systematic Review
    Iftikhar, Sadaf
    Alhaddad, Sarah F.
    Paulsingh, Christian N.
    Riaz, Muhammad Faisal
    Garg, Gourav
    Umeano, Lotanna
    Hamid, Pousette
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [9] Effect Of Angiotensin-Converting-Enzyme Inhibitors On Idiopathic Pulmonary Fibrosis
    Gandra, N.
    Noth, I.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2013, 187
  • [10] EFFECT OF PROTON PUMP INHIBITORS ON CYSTIC FIBROSIS (CF) PULMONARY EXACERBATIONS IN ADULTS
    DiMango, E.
    Walker, P.
    Keating, C.
    Berdella, M.
    Robinson, B.
    Langfelder-Schwind, E.
    Levy, D.
    Liu, X.
    PEDIATRIC PULMONOLOGY, 2012, 47 : 353 - 353
123